Unparalleled in its scope and depth, this book brings together proteomic approaches in diagnosis and treatment from all clinical fields, including clinical toxicology.

The result is a new discipline in molecular medicine that will revolutionize the treatment and prevention of cancer, stroke and other severe diseases.

Following an overview of clinical proteomics, the authors look at the technologies available, before moving on to cancer, cardiopulmonary disease, diabetes and stroke. 

A whole section is devoted to toxicity and the work is rounded off with a discussion of the future of clinical proteomics. 

Over 100 authors have contributed to this outstanding book and written 34 articles, which demonstrate that proteomics is an interesting new approach to improve diagnostics and treatment. 

Clinical Proteomics is an invaluable resource for all clinical and pharmaceutical researchers in academia and industry.